Researchers from Chulalongkorn University have successfully established a novel human antibody heavy chain variable (VH)-only domain with potent activity against folate receptor alpha-positive solid tumor in CAR-T cell format....
Researchers from Chulalongkorn University have successfully developed MUC1-targeting CAR T cells engineered to secrete an anti-PD-1 antibody, derived from nivolumab, to enhance their effectiveness against solid tumors. These modified...
Researchers have found a new way to make the body’s immune cells (T cells) fight lung cancer more effectively. They used a special “connector” protein that helps T cells...
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Researchers have developed a new type of engineered immune cell, called “fifth-generation CAR T cells,” to fight cholangiocarcinoma, a severe bile duct cancer that is often hard to treat....
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component...
Researchers have developed a new method to treat multiple myeloma, a type of blood cancer. They engineered a type of immune cell called T cells to produce and release...
Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...
Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...